Global Actinic Keratosis Treatment Supply, Demand and Key Producers, 2024-2030

Page: 123

Published Date: 21 Feb 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Actinic Keratosis Treatment market size is expected to reach $ 4819.8 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).

In North America, key players of actinic keratosis treatment include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera, Almirall and Tolmar Pharmaceutical, etc. The top ten players hold a share about 11% of North America market. In terms of product type, destructive treatment is the largest segment, occupied for a share of 80%, and in terms of application, clinic has a share about 63 percent.

Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.

This report studies the global Actinic Keratosis Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Actinic Keratosis Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Actinic Keratosis Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Actinic Keratosis Treatment total market, 2019-2030, (USD Million)
Global Actinic Keratosis Treatment total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Actinic Keratosis Treatment total market, key domestic companies and share, (USD Million)
Global Actinic Keratosis Treatment revenue by player and market share 2019-2024, (USD Million)
Global Actinic Keratosis Treatment total market by Type, CAGR, 2019-2030, (USD Million)
Global Actinic Keratosis Treatment total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Actinic Keratosis Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera and Almirall, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Actinic Keratosis Treatment market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Actinic Keratosis Treatment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Actinic Keratosis Treatment Market, Segmentation by Type
Destructive Treatment
Photodynamic Therapy
Topical Medications
Others

Global Actinic Keratosis Treatment Market, Segmentation by Application
Hospital
Clinic
Others

Companies Profiled:
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical

Key Questions Answered
1. How big is the global Actinic Keratosis Treatment market?
2. What is the demand of the global Actinic Keratosis Treatment market?
3. What is the year over year growth of the global Actinic Keratosis Treatment market?
4. What is the total value of the global Actinic Keratosis Treatment market?
5. Who are the major players in the global Actinic Keratosis Treatment market?

Table of Contents

1 Supply Summary
    1.1 Actinic Keratosis Treatment Introduction
    1.2 World Actinic Keratosis Treatment Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Actinic Keratosis Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Actinic Keratosis Treatment Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.3 China Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.4 Europe Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.5 Japan Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.6 South Korea Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.7 ASEAN Actinic Keratosis Treatment Market Size (2019-2030)
        1.3.8 India Actinic Keratosis Treatment Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Actinic Keratosis Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Actinic Keratosis Treatment Major Market Trends

2 Demand Summary
    2.1 World Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.2 World Actinic Keratosis Treatment Consumption Value by Region
        2.2.1 World Actinic Keratosis Treatment Consumption Value by Region (2019-2024)
        2.2.2 World Actinic Keratosis Treatment Consumption Value Forecast by Region (2025-2030)
    2.3 United States Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.4 China Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.5 Europe Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.6 Japan Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.7 South Korea Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.8 ASEAN Actinic Keratosis Treatment Consumption Value (2019-2030)
    2.9 India Actinic Keratosis Treatment Consumption Value (2019-2030)

3 World Actinic Keratosis Treatment Companies Competitive Analysis
    3.1 World Actinic Keratosis Treatment Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Actinic Keratosis Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Actinic Keratosis Treatment in 2023
        3.2.3 Global Concentration Ratios (CR8) for Actinic Keratosis Treatment in 2023
    3.3 Actinic Keratosis Treatment Company Evaluation Quadrant
    3.4 Actinic Keratosis Treatment Market: Overall Company Footprint Analysis
        3.4.1 Actinic Keratosis Treatment Market: Region Footprint
        3.4.2 Actinic Keratosis Treatment Market: Company Product Type Footprint
        3.4.3 Actinic Keratosis Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Actinic Keratosis Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Actinic Keratosis Treatment Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Actinic Keratosis Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Actinic Keratosis Treatment Consumption Value Comparison
        4.2.1 United States VS China: Actinic Keratosis Treatment Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Actinic Keratosis Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Actinic Keratosis Treatment Companies and Market Share, 2019-2024
        4.3.1 United States Based Actinic Keratosis Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Actinic Keratosis Treatment Revenue, (2019-2024)
    4.4 China Based Companies Actinic Keratosis Treatment Revenue and Market Share, 2019-2024
        4.4.1 China Based Actinic Keratosis Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Actinic Keratosis Treatment Revenue, (2019-2024)
    4.5 Rest of World Based Actinic Keratosis Treatment Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Actinic Keratosis Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Actinic Keratosis Treatment Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Actinic Keratosis Treatment Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Destructive Treatment
        5.2.2 Photodynamic Therapy
        5.2.3 Topical Medications
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Actinic Keratosis Treatment Market Size by Type (2019-2024)
        5.3.2 World Actinic Keratosis Treatment Market Size by Type (2025-2030)
        5.3.3 World Actinic Keratosis Treatment Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Actinic Keratosis Treatment Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Actinic Keratosis Treatment Market Size by Application (2019-2024)
        6.3.2 World Actinic Keratosis Treatment Market Size by Application (2025-2030)
        6.3.3 World Actinic Keratosis Treatment Market Size by Application (2019-2030)

7 Company Profiles
    7.1 DUSA Pharmaceuticals
        7.1.1 DUSA Pharmaceuticals Details
        7.1.2 DUSA Pharmaceuticals Major Business
        7.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Product and Services
        7.1.4 DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 DUSA Pharmaceuticals Recent Developments/Updates
        7.1.6 DUSA Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Actinic Keratosis Treatment Product and Services
        7.2.4 Novartis Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Perrigo
        7.3.1 Perrigo Details
        7.3.2 Perrigo Major Business
        7.3.3 Perrigo Actinic Keratosis Treatment Product and Services
        7.3.4 Perrigo Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Perrigo Recent Developments/Updates
        7.3.6 Perrigo Competitive Strengths & Weaknesses
    7.4 LEO Pharma
        7.4.1 LEO Pharma Details
        7.4.2 LEO Pharma Major Business
        7.4.3 LEO Pharma Actinic Keratosis Treatment Product and Services
        7.4.4 LEO Pharma Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 LEO Pharma Recent Developments/Updates
        7.4.6 LEO Pharma Competitive Strengths & Weaknesses
    7.5 Bausch Health
        7.5.1 Bausch Health Details
        7.5.2 Bausch Health Major Business
        7.5.3 Bausch Health Actinic Keratosis Treatment Product and Services
        7.5.4 Bausch Health Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Bausch Health Recent Developments/Updates
        7.5.6 Bausch Health Competitive Strengths & Weaknesses
    7.6 Taro Pharmaceutical
        7.6.1 Taro Pharmaceutical Details
        7.6.2 Taro Pharmaceutical Major Business
        7.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Product and Services
        7.6.4 Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Taro Pharmaceutical Recent Developments/Updates
        7.6.6 Taro Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Galderma (Nestle)
        7.7.1 Galderma (Nestle) Details
        7.7.2 Galderma (Nestle) Major Business
        7.7.3 Galderma (Nestle) Actinic Keratosis Treatment Product and Services
        7.7.4 Galderma (Nestle) Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Galderma (Nestle) Recent Developments/Updates
        7.7.6 Galderma (Nestle) Competitive Strengths & Weaknesses
    7.8 Biofrontera
        7.8.1 Biofrontera Details
        7.8.2 Biofrontera Major Business
        7.8.3 Biofrontera Actinic Keratosis Treatment Product and Services
        7.8.4 Biofrontera Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Biofrontera Recent Developments/Updates
        7.8.6 Biofrontera Competitive Strengths & Weaknesses
    7.9 Almirall
        7.9.1 Almirall Details
        7.9.2 Almirall Major Business
        7.9.3 Almirall Actinic Keratosis Treatment Product and Services
        7.9.4 Almirall Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Almirall Recent Developments/Updates
        7.9.6 Almirall Competitive Strengths & Weaknesses
    7.10 Tolmar Pharmaceutical
        7.10.1 Tolmar Pharmaceutical Details
        7.10.2 Tolmar Pharmaceutical Major Business
        7.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Product and Services
        7.10.4 Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Tolmar Pharmaceutical Recent Developments/Updates
        7.10.6 Tolmar Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Actinic Keratosis Treatment Industry Chain
    8.2 Actinic Keratosis Treatment Upstream Analysis
    8.3 Actinic Keratosis Treatment Midstream Analysis
    8.4 Actinic Keratosis Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Actinic Keratosis Treatment Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Actinic Keratosis Treatment Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Actinic Keratosis Treatment Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Actinic Keratosis Treatment Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Actinic Keratosis Treatment Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Actinic Keratosis Treatment Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Actinic Keratosis Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Actinic Keratosis Treatment Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Actinic Keratosis Treatment Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Actinic Keratosis Treatment Players in 2023
    Table 12. World Actinic Keratosis Treatment Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Actinic Keratosis Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Actinic Keratosis Treatment Player
    Table 15. Actinic Keratosis Treatment Market: Company Product Type Footprint
    Table 16. Actinic Keratosis Treatment Market: Company Product Application Footprint
    Table 17. Actinic Keratosis Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Actinic Keratosis Treatment Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Actinic Keratosis Treatment Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Actinic Keratosis Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Actinic Keratosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Actinic Keratosis Treatment Revenue Market Share (2019-2024)
    Table 23. China Based Actinic Keratosis Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Actinic Keratosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Actinic Keratosis Treatment Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Actinic Keratosis Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Actinic Keratosis Treatment Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Actinic Keratosis Treatment Revenue Market Share (2019-2024)
    Table 29. World Actinic Keratosis Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Actinic Keratosis Treatment Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Actinic Keratosis Treatment Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Actinic Keratosis Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Actinic Keratosis Treatment Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Actinic Keratosis Treatment Market Size by Application (2025-2030) & (USD Million)
    Table 35. DUSA Pharmaceuticals Basic Information, Area Served and Competitors
    Table 36. DUSA Pharmaceuticals Major Business
    Table 37. DUSA Pharmaceuticals Actinic Keratosis Treatment Product and Services
    Table 38. DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. DUSA Pharmaceuticals Recent Developments/Updates
    Table 40. DUSA Pharmaceuticals Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Actinic Keratosis Treatment Product and Services
    Table 44. Novartis Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Perrigo Basic Information, Area Served and Competitors
    Table 48. Perrigo Major Business
    Table 49. Perrigo Actinic Keratosis Treatment Product and Services
    Table 50. Perrigo Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Perrigo Recent Developments/Updates
    Table 52. Perrigo Competitive Strengths & Weaknesses
    Table 53. LEO Pharma Basic Information, Area Served and Competitors
    Table 54. LEO Pharma Major Business
    Table 55. LEO Pharma Actinic Keratosis Treatment Product and Services
    Table 56. LEO Pharma Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. LEO Pharma Recent Developments/Updates
    Table 58. LEO Pharma Competitive Strengths & Weaknesses
    Table 59. Bausch Health Basic Information, Area Served and Competitors
    Table 60. Bausch Health Major Business
    Table 61. Bausch Health Actinic Keratosis Treatment Product and Services
    Table 62. Bausch Health Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Bausch Health Recent Developments/Updates
    Table 64. Bausch Health Competitive Strengths & Weaknesses
    Table 65. Taro Pharmaceutical Basic Information, Area Served and Competitors
    Table 66. Taro Pharmaceutical Major Business
    Table 67. Taro Pharmaceutical Actinic Keratosis Treatment Product and Services
    Table 68. Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Taro Pharmaceutical Recent Developments/Updates
    Table 70. Taro Pharmaceutical Competitive Strengths & Weaknesses
    Table 71. Galderma (Nestle) Basic Information, Area Served and Competitors
    Table 72. Galderma (Nestle) Major Business
    Table 73. Galderma (Nestle) Actinic Keratosis Treatment Product and Services
    Table 74. Galderma (Nestle) Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Galderma (Nestle) Recent Developments/Updates
    Table 76. Galderma (Nestle) Competitive Strengths & Weaknesses
    Table 77. Biofrontera Basic Information, Area Served and Competitors
    Table 78. Biofrontera Major Business
    Table 79. Biofrontera Actinic Keratosis Treatment Product and Services
    Table 80. Biofrontera Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Biofrontera Recent Developments/Updates
    Table 82. Biofrontera Competitive Strengths & Weaknesses
    Table 83. Almirall Basic Information, Area Served and Competitors
    Table 84. Almirall Major Business
    Table 85. Almirall Actinic Keratosis Treatment Product and Services
    Table 86. Almirall Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Almirall Recent Developments/Updates
    Table 88. Tolmar Pharmaceutical Basic Information, Area Served and Competitors
    Table 89. Tolmar Pharmaceutical Major Business
    Table 90. Tolmar Pharmaceutical Actinic Keratosis Treatment Product and Services
    Table 91. Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 92. Global Key Players of Actinic Keratosis Treatment Upstream (Raw Materials)
    Table 93. Actinic Keratosis Treatment Typical Customers
List of Figure
    Figure 1. Actinic Keratosis Treatment Picture
    Figure 2. World Actinic Keratosis Treatment Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Actinic Keratosis Treatment Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Actinic Keratosis Treatment Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Actinic Keratosis Treatment Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Actinic Keratosis Treatment Revenue (2019-2030) & (USD Million)
    Figure 13. Actinic Keratosis Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Actinic Keratosis Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Actinic Keratosis Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Actinic Keratosis Treatment by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Actinic Keratosis Treatment Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Actinic Keratosis Treatment Markets in 2023
    Figure 27. United States VS China: Actinic Keratosis Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Actinic Keratosis Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Actinic Keratosis Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Actinic Keratosis Treatment Market Size Market Share by Type in 2023
    Figure 31. Destructive Treatment
    Figure 32. Photodynamic Therapy
    Figure 33. Topical Medications
    Figure 34. Others
    Figure 35. World Actinic Keratosis Treatment Market Size Market Share by Type (2019-2030)
    Figure 36. World Actinic Keratosis Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Actinic Keratosis Treatment Market Size Market Share by Application in 2023
    Figure 38. Hospital
    Figure 39. Clinic
    Figure 40. Others
    Figure 41. Actinic Keratosis Treatment Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical

Related Reports

Global Actinic Keratosis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Actinic Keratosis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 06 Jun 2021

date Medical Care

The Actinic Keratosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Actinic Keratosis Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Actinic Keratosis Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

Global Actinic Keratosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Actinic Keratosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Global Actinic Keratosis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Actinic Keratosis Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Actinic Keratosis Treatment market size was valued at USD 3408.9 million in 2023 and is forecast to a readjusted size of USD 4819.8 million by 2030 with a CAGR of 5.1% during review period.

Product Tags

actinic keratosis treatment

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>